merck & co. inc. (MRK:New York)
Executive Profile*
Adel A. F. Mahmoud M.D., Ph.D.Chief Medical Advisor of Vaccines & Infectious Diseases, Merck & Co. Inc. |
| Age | Total Calculated Compensation | This person is connected to 101 board members in 9 different organizations across 6 different industries. See Board Relationships |
| 70 | -- |
Background*
Dr. Adel A. F. Mahmoud, MD, PhD has been a Professor at Princeton University in the Department of Molecular Biology and the Woodrow Wilson School of Public and International Affairs since 2007. Dr. Mahmoud served as the Chief Medical Advisor, Vaccines and Infectious Diseases of Merck & Co., Inc. since September 1, 2005. He served as the President of Merck Vaccines, a subsidiary of Merck & Co. Inc. from May 1999 to 2005. Prior to November 1998, Dr. Mahmoud was the John ...
Corporate Headquarters*One Merck DriveWhitehouse Station, New Jersey 08889-0100 United States Phone: 908-423-1000 Fax: 908-735-1253 Board Members Memberships*2006-Present Independent Director, Member of Science, Innovation & Technology Committee and Member of Corporate Governance & Nominating Committee 2011-Present Director and Member of Nominating & Corporate Governance Committee 2012-Present Director, Member of Nomination & Corporate Governance Committee and Member of Compensation Committee 2012-Present Director 2012-Present Director 2013-Present Chairman
Education*PhD 1971 London School Of Hygiene And Tropical Medicine Unknown/Other Education Faculty of Medicine, University of Ain Shams MD 1963 Cairo University
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*There is no Stock Options data available.Total Compensation*There is no Total Compensation data available. |
| Recently Viewed | |||
| MRK:US | $47.16 USD | -0.17 | |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Marijn E. Dekkers Ph.D. | Chairman of Management Board and Chief Executive Officer Bayer AG | €3.0M |
| Andrew Philip Witty | Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee GlaxoSmithKline plc | 1.9M GBP |
| Christopher A. Viehbacher | Chief Executive Officer, Director and Member of Strategy Committee Sanofi | €3.5M |
| Severin Schwan | Chief Executive Officer and Director Roche Holding AG | SFr.6.5M |
| Jean-Paul Agon | Chairman, Chief Executive Officer and Chairman of Strategy & Sustainable Development Committee L'Oreal SA | €3.9M | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Chicago, IL | Merck GroupPosted: May 21
- Boston, MA | Merck GroupPosted: May 21
- Philadelphia, PA | Merck GroupPosted: May 23
- Nashua, NH | Merck GroupPosted: May 20
Sponsored Financial Commentaries
Sponsored Links
To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








